Encompass Health Net Common Equity Issued/Repurchased 2010-2025 | EHC

Encompass Health annual/quarterly net common equity issued/repurchased history and growth rate from 2010 to 2025. Net common equity issued/repurchased can be defined as the net dollar amount of transactions to issue and repurchase common stock.
  • Encompass Health net common equity issued/repurchased for the quarter ending March 31, 2025 was $-0.031B, a 0% increase year-over-year.
  • Encompass Health net common equity issued/repurchased for the twelve months ending March 31, 2025 was $-0.072B, a 0% increase year-over-year.
  • Encompass Health annual net common equity issued/repurchased for 2024 was $-0.031B, a 0% decline from 2023.
  • Encompass Health annual net common equity issued/repurchased for 2023 was $0B, a 0% decline from 2022.
  • Encompass Health annual net common equity issued/repurchased for 2022 was $0B, a 0% decline from 2021.
Encompass Health Annual Net Common Equity Issued/Repurchased
(Millions of US $)
2024 $-31
2023 $N/A
2022 $N/A
2021 $N/A
2020 $N/A
2019 $-46
2018 $N/A
2017 $-12
2016 $-66
2015 $-45
2014 $-43
2013 $-219
2012 $N/A
2011 $N/A
2010 $N/A
2009 $N/A
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $12.183B $5.373B
Encompass Health Corporation is a provider of integrated healthcare services. It offers both facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The company delivers high-quality, cost-effective, integrated care in the healthcare space. It provides a continuum of facility-based and home-based post-acute services for its patients and their families, which will gain more prevalence as coordinated care and integrated delivery payment models, such as accountable care organizations and bundled payment arrangements. The company operates through two segments: Inpatient Rehabilitation as well as Home Health and Hospice business.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.868B 19.58
DaVita (DVA) United States $10.978B 15.44
Chemed (CHE) United States $8.483B 26.66
Elanco Animal Health (ELAN) United States $6.417B 13.74
Option Care Health (OPCH) United States $5.441B 24.26
RadNet (RDNT) United States $4.587B 291.14
Amedisys (AMED) United States $3.105B 20.89
LifeStance Health (LFST) United States $2.271B 0.00
Addus HomeCare (ADUS) United States $2.054B 22.55
Astrana Health (ASTH) United States $1.524B 37.75
U.S Physical Therapy (USPH) United States $1.213B 31.31
Aveanna Healthcare Holdings (AVAH) United States $1.169B 66.56
Pennant (PNTG) United States $1.042B 38.25
Atai Life Sciences (ATAI) Germany $0.331B 0.00
Daxor (DXR) United States $0.037B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
Ontrak (OTRK) United States $0.007B 0.00
Psychemedics (PMD) United States $0.000B 0.00